GLP-1 medicines have changed the way obesity can be treated. Drugs such as semaglutide and tirzepatide reduce appetite and can produce substantial weight loss. Even lower doses can have measurable effects. The STEP 2 trial, for example, found that people with type 2 diabetes taking 1.0 mg of semaglutide lost about 7% of their starting […]